Selection of phage‐displayed llama single‐domain antibodies that transmigrate across human blood‐brain barrier endothelium
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Delivery to the brain of drugs, peptides, and genes depends on the availability of brain‐specific delivery vectors. We used a phage‐displayed library of llama single‐domain antibodies (sdAbs) to enrich for species that selectively bind to and are internalized by human cerebromicrovascular endothelial cells (HCEC). Two sdAbs (FC5 and FC44) were selected, sequenced, subcloned, and expressed as fusion proteins with c‐Myc‐His 5 tags. Similar to phage‐displayed sdAbs, soluble FC5 and FC44 were shown to selectively bind HCEC and to transmigrate across an in vitro human blood‐brain barrier (BBB) model. Both FC5 and FC44, in contrast to an unrelated llama sdAb, were also detected in the brain after i.v. injection into mice. These small (~14 kDa) antibodies have characteristics essential for a carrier‐vector and can be used to facilitate drug transport across the BBB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Selection and identification of single domain antibody fragments from camel heavy‐chain antibodies
Arbabi Ghahroudi, M., Desmyter, A., Wyns, L., Hamers, R., & Muyldermans, S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01062-4 · Cited by 768
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 481
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
Pardridge, W. M. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00001 · Cited by 328
Bowman, P. D., Ennis, S. R., Rarey, K. E., Lorris Betz, A., & Goldstein, G. W. (1983) · Annals of Neurology · doi:10.1002/ana.410140403 · Cited by 321
Drug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo Models
Dehouck, M., Jolliet‐Riant, P., Brée, F., Fruchart, J., Cecchelli, R., & Tillement, J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10055.x · Cited by 286
Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge, W. M., Triguero, D., Yang, J., & Cancilla, P. A. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13060-7 · Cited by 275
Harmsen, M. M., Ruuls, R. C., Nijman, I. J., Niewold, T. A., Frenken, L. G. J., & de Geus, B. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00081-x · Cited by 217
Carrier-mediated or specialized transport of drugs across the blood–brain barrier
Tsuji, A., & Tamai, I. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00084-2 · Cited by 174
Toward Selection of Internalizing Antibodies from Phage Libraries
Becerril, B., Poul, M., & Marks, J. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0177 · Cited by 158
Muyldermans, S., & Lauwereys, M. (1999) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199903/04)12:2<131::aid-jmr454>3.0.co;2-m · Cited by 158
Targeted gene delivery to mammalian cells by filamentous bacteriophage
Poul, M., & Marks, J. D. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2678 · Cited by 145
Muruganandam, A., Herx, L. M., Monette, R., Durkin, J. P., & Stanimirovic, D. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367354 · Cited by 142
Self-citationTanha, J., Dubuc, G., Hirama, T., Narang, S. A., & MacKenzie, C. R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00027-3 · Cited by 135
Self-citationCultured human and canine endothelial cells from brain microvessels
Gerhart, D. Z., Broderius, M. A., & Drewes, L. R. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90047-0 · Cited by 112
Banks, W. A., Akerstrom, V., & Kastin, A. J. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.4.533 · Cited by 92
Optimal Design Features of Camelized Human Single-domain Antibody Libraries
Tanha, J., Xu, P., Chen, Z., Ni, F., Kaplan, H. A., Narang, S. A., & MacKenzie, C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100770200 · Cited by 82
Self-citationBoado, R. J., Tsukamoto, H., & Pardridge, W. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9800836 · Cited by 69
Li, J. Y., Sugimura, K., Boado, R. J., Lee, H., Zhang, C., Dübel, S., & Pardridge, W. M. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.9.787 · Cited by 63
Vector-mediated peptide drug delivery to the brain
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00007-t · Cited by 58
Stanimirovic, D. B., Ball, R., & Durkin, J. P. (1997) · Glia · doi:10.1002/(sici)1098-1136(199702)19:2<123::aid-glia4>3.0.co;2-1 · Cited by 49
Self-citationGirod, J., Fénart, L., Régina, A., Dehouck, M., Hong, G., Scherrmann, J., Cecchelli, R., & Roux, F. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02002.x · Cited by 32
Cited by
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Properties, production, and applications of camelid single-domain antibody fragments
Harmsen, M. M., & De Haard, H. J. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1142-2 · Cited by 809
“For their use in targeting drugs across the blood–brain barrier (BBB) into the brain, VHHs were selected that transmigrate the human BBB in an in vitro model and accumulate in the brain after intravenous injection into mice (Muruganandam et al. 2002).”
BackgroundApproaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Metadata
- Authors
- Muruganandam, A., Tanha, J., Narang, S., & Stanimirovic, D.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-12-28
- Volume
- 16
- Issue
- 2
- Pages
- 1-22
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2149218172
- Cited by
- 260
- References
- 28
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.